Mesh revision surgery — any surgical procedure to address complications from a prior mesh implant — is one of the strongest indicators of case value in transvaginal mesh litigation. Courts and juries understand that revision surgery is not elective: no woman chooses to undergo additional pelvic surgery unless the complications of her mesh are severe enough to require intervention. Each revision surgery is documented in operative reports, anesthesia records, and hospital bills that form concrete economic damages.

Revision surgery also carries its own risks: bladder and bowel injury during mesh dissection, blood loss, infection, scarring, and — paradoxically — worsening pain in some cases as scar tissue from the revision creates new sources of nerve entrapment. Women who undergo multiple revisions often develop a complex chronic pain syndrome that is more difficult to treat than their original mesh complications.